CGN Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.56M | Sell |
|
|||||
|
2025
Q2 | $2.74M | Buy |
|
|||||
|
2025
Q1 | $2.77M | Sell |
|
|||||
|
2024
Q4 | $3.24M | Buy |
|
|||||
|
2024
Q3 | $2.8M | Buy |
|
|||||
|
2024
Q2 | $2.46M | Buy |
|
|||||
|
2024
Q1 | $779K | Buy |
|
|||||
|
2023
Q4 | $575K | Sell |
|
|||||
|
2023
Q3 | $697K | Buy |
|
|||||
|
2023
Q2 | $373K | Sell |
|
|||||
|
2023
Q1 | $282K | Hold |
|
|||||
|
2022
Q4 | $301K | Hold |
|
|||||
|
2022
Q3 | $266K | Buy |
|
|||||
|
2022
Q2 | $247K | Buy |
|
|||||
|
2022
Q1 | $213K | Sell |
|
|||||
|
2021
Q4 | $216K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $412K | Sell |
|
|||||
|
2021
Q1 | $340K | Buy |
|
|||||
|
2020
Q4 | $297K | Buy |
|